Microbot Medical Inc. (MBOT)
NASDAQ: MBOTHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MBOT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $45.67M
- EPS (TTM)
- -$0.27
- Dividend yield
- None
- 52-week range
- 0.52 – 2.86
- Day range
- 0.6601 – 0.75
- Volume / Avg
- 1.72M / 922.53K
- Beta
- —
- Shares outstanding
- 67.16M
52-week range
MBOT stock today
Microbot Medical (MBOT) closed at $0.68 on Nov 20, down 8.52% (-$0.0633), versus the S&P 500's 3.70% decline. At this level, MBOT sits near the bottom of its 52-week range of $0.52 to $2.86: 76.2% below the high, set on Mar 11, 2026 and 30.8% above the low. MBOT is down 66.0% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 62.8%.
Microbot Medical has posted a net loss over the last twelve months (EPS of -$0.27), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Microbot Medical
Company profileMicrobot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Harel Gadot
- Headquarters
- Hingham, MA
- Employees
- 43
- Website
- microbotmedical.com
Financial highlights
Full financialsMicrobot Medical reported a net loss of $13.1 million, compared with a loss of $11.4 million a year earlier. Diluted earnings per share came in at -$0.29.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Growth | — | — | — | — | — |
| Net income | $-13.14M | $-11.44M | $-10.74M | $-13.17M | $-11.31M |
| EPS (diluted) | $-0.29 | $-0.73 | $-1.05 | $-1.81 | $-1.59 |
Analyst forecast
ForecastConsensus (3 analysts)
strong_buy
Avg. price target
$6.33+830.88%
- Strong buy 0
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 13, 2026
- EPS actual vs est.
- $-0.09 vs $-0.08
- Surprise
- -12.50%
MBOT news
All MBOT news- Microbot Medical Inc. Reports Q3 2026 Revenue of $72,000 and Highlights LIBERTY System ProgressNasdaq
- Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating AchievementsGlobeNewswire
- Microbot Medical Inc. Granted Canadian Patent, Bringing Global Portfolio to 45 Issued PatentsNasdaq
- Microbot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization ExpansionGlobeNewswire
- Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic SystemGlobeNewswire
- Microbot Medical® Attending Key Medical Conference to Engage with Decision-makers as it Continues to Expand Presence Across the U.S.GlobeNewswire
- Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property PortfolioGlobeNewswire
Microbot Medical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DXRDaxor Corporation | 7.45 | -7.33% | $43.49M | vs MBOT |
| SRTSSensus Healthcare Inc. | 2.26 | -4.24% | $37.20M | vs MBOT |
| LNSRLENSAR Inc. | 4.46 | -3.88% | $54.83M | vs MBOT |
| MDAISpectral AI Inc. Class A | 1.04 | -20.61% | $33.47M | vs MBOT |
| TELATELA Bio Inc. | 0.6885 | -5.27% | $31.11M | vs MBOT |
| XTNTXtant Medical Holdings Inc. | 0.21 | -2.82% | $29.49M | vs MBOT |
| NSPRInspireMD Inc. | 0.54 | -12.97% | $29.23M | vs MBOT |
| NEPHNephros Inc. | 2.61 | -8.10% | $28.37M | vs MBOT |
Indexes, lists and sector
Microbot Medical stock FAQ
What is Microbot Medical's stock price today?
MBOT last traded at $0.68 as of Nov 20, 4:00 PM EST, down 8.52% on the day. Prices are delayed at least 15 minutes.
Does Microbot Medical pay a dividend?
No. Microbot Medical does not currently pay a regular cash dividend.
Who is Microbot Medical's CEO?
Mr. Harel Gadot is the chief executive officer of Microbot Medical Inc., which has about 43 employees.
Has MBOT ever split its stock?
Yes. The most recent MBOT stock split was a 1-for-15 split on Sep 5, 2018, one of 4 splits on record.
What is the MBOT 52-week high?
The 52-week high for MBOT is $2.86 and the 52-week low is $0.52. The stock is currently 76.2% below its high.